Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1Gastrointestinal 1

Conditions

Barrett Esophagus 2Zollinger-Ellison Syndrome 1Xerostomia 1Stomach Ulcer 1Stomach Neoplasms 1Oropharyngeal Neoplasms 1Mucositis 1Inflammation 1Helicobacter Infections 1Heartburn 1Head and Neck Neoplasms 1Gastroesophageal Reflux 1Gastritis, Atrophic 1Esophagitis, Peptic 1

Interventions

pembrolizumab 29Cetuximab 11Nivolumab 10Fluorouracil 8Cyclophosphamide 8Cisplatin 8Carboplatin 8fludarabine 7atezolizumab 7Blood Specimen Collection 7cemiplimab 6Radiotherapy 6Drug Therapy 6Immune Checkpoint Inhibitors 5Gemcitabine 5Paclitaxel 4Docetaxel 4Capecitabine 4Biopsy 4spartalizumab 3avelumab 3Surveys and Questionnaires 3Pemetrexed 3Oncolytic Virotherapy 3Nicotine 3Magnetic Resonance Spectroscopy 3Irinotecan 3Ipilimumab 3Interleukin-2 3Bortezomib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Dexlansoprazole × Gastrointestinal × Clear all
NCT00928161 2012-09-07

Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy

M.D. Anderson Cancer Center

Phase NA Withdrawn
GastrointestinalHead & NeckOther

Gastroesophageal Reflux, Head and Neck Neoplasms, Heartburn, Oropharyngeal Neoplasms, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡